Avenzoar Pharmaceuticals, Inc. is seeking to leverage its growth strategy by acquiring or licensing new therapeutics, in addition to developing its new products.
Partnering is a fundamental part of Avenzoar Pharmaceuticals' business strategy. We are seeking to expand our offerings by adding appropriate development programs into our pipeline. Our management team has a wealth of experience in a variety of partnership settings. We are currently interested in the following types of collaborations: In-licensing new product candidates, accessing value-added API, and manufacturing and distribution services.
If you are interested in discussing partnership or business development opportunities, please contact us at: firstname.lastname@example.org Tel: 1.310-502-0770
The following organizations have meaningfully contributed to the discovery and pre-clinical development work for AP-001 and several other potential compounds:
The Hirshberg Foundation
The Cedars-Sinai Medical Center
The National Institute of Health